Hybridoma-inspired strategy crafts tailored multifunctional exosomes for precision therapy
Open Access
- 9 September 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (37)
Abstract
Engineering functional exosomes represents a cutting-edge approach in biomedicine, holding the promise to transform targeted therapy. However, challenges such as achieving consistent modification and scalability have limited their wider adoption. Herein, we introduce a universal and effective strategy for engineering multifunctional exosomes through cell fusion. The hybrid-cell-derived exosomes could combine the functional properties of both parental cells and be readily produced by passaging. This method enables customization and large-scale production of exosomes with specific functionalities, potentially advancing precision therapies across a wide array of diseases. As demonstrated in Alzheimer’s disease (AD) models, exosomes derived from hybrid cells (HCs) (H/Exos) of mesenchymal stem cells (MSCs) and neutrophils efficiently targeted AD-affected areas via LFA-1/ICAM-1 and improved the cognition of AD mice. Beyond directly promoting neural repair and inhibiting inflammation, we surprisingly found that H/Exos increased microglia abundance, modulated microglia gene expression, enhanced the endocytic and lysosomal function, and promoted microglial phagocytic phenotypic differentiation to clear Aβ. This hybridoma-inspired strategy offers a versatile and practical way to engineer exosomes with desired therapeutic functions, representing a promising direction for personalized therapies.Keywords
Funding Information
- MOST | National Natural Science Foundation of China (32371392)
- MOST | National Natural Science Foundation of China (32171334)
- MOST | National Natural Science Foundation of China (12272071)
- MOST | National Natural Science Foundation of China (82100192)
- CSTC | Natural Science Foundation of Chongqing Municipality (CSTB2023NSCQ-LZX0032)
- MOST | National Natural Science Foundation of China (22407020)
- Joint Project of Chongqing Health Commission and Science and Technology Bureau (2025ZDXM011)
This publication has 46 references indexed in Scilit:
- Human microglial state dynamics in Alzheimer’s disease progressionCell, 2023
- TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathwaysCell, 2022
- Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer’s diseaseBrain, Behavior, and Immunity, 2022
- Mesenchymal Stem Cell‐Derived Extracellular Vesicles with High PD‐L1 Expression for Autoimmune Diseases TreatmentAdvanced Materials, 2021
- Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s DiseaseCell, 2020
- Mesenchymal Stem Cells Therapy Improved the Streptozotocin-Induced Behavioral and Hippocampal Impairment in RatsMolecular Neurobiology, 2019
- LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s DiseaseCell, 2019
- Disorders of lysosomal acidification—The emerging role of v-ATPase in aging and neurodegenerative diseaseAgeing Research Reviews, 2016
- Dynamic structural remodelling of microglia in health and disease: A review of the models, the signals and the mechanismsBrain, Behavior, and Immunity, 2014
- P-selectin mediates neutrophil adhesion to endothelial cell bordersJournal of Leukocyte Biology, 1999